Skip to content
Aperlena
Language:

Norway - Laboratory reagents - Reference substances for forensic medicine to Oslo University Hospital

Original Norway - Laboratory reagents - Reference substances for forensic medicine to Oslo University Hospital.

Upcoming Prior information notice No deadline published
Watch this tender

We email you if the deadline moves or a correction is published. Free. Log in

Summary

Machine-generated summary

Oslo University Hospital, Department of Forensic Sciences, is procuring reference substances and internal standards for legal toxicology analysis of drugs. The department handled about 35,000 cases in 2025 and routinely examines samples for up to 110 substances, requiring a broad and flexible assortment. Certified reference substances from ISO/IEC 17025 and ISO 17034 accredited manufacturers are preferred, and parallel agreements are needed because reference material from two different manufacturers is used. Estimated annual value is NOK 550,000, with variable assortment extraction making up around 85% of contract value. No deadline is stated in the description.

Description

The Department of Forensic Sciences at Oslo University Hospital shall procure reference substances and internal standards that are used in legal toxicology analyses of drugs and drugs. In 2025, the department received samples from approx. 35,000 cases. Routinely samples are examined for up to 110 substances, but the department's repertoire spans a large number of substances. The repertoire is changed and adapted to the use of drugs in the community - there is, therefore, a need for flexibility in the assortment and access to a large assortment. Certified reference substances (CRM) or reference substances from manufacturers are preferably used accredited in accordance with ISO/IEC 17025 and ISO 17034. The aim of analysing sanctioning samples is to use reference material from two different manufacturers for preparation of control and standard for each individual substance that is analysed, there is a need for parallel agreements. Based on the price level of the existing tenderers in 2024-2025, the estimated annual value is NOK 550,000,-. The extraction of products in variable assortment makes up the largest part of the contract ́s value, approx. 85% in the last year.

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 2 weeks ago

View the official notice

More from this buyer

Full buyer profile

82 open tenders right now

Who usually wins this buyer's contracts in this sector

Company Wins Total awarded Last win
Siemens Healthcare AS 2 €39.6M Sep 2026
GE HEALTHCARE NORGE AS 2 €1.1M Apr 2026
Adcare AS 2 €467,655 Feb 2026
OneMed AS 2 €248,469 Aug 2026
Becton Dickinson Norway AS; Mediq Norge AS; Medistim Norge AS; Polytech Health & Aesthetics Nordics AB 2 n/a Aug 2026

Based on 32 awards with a linked company profile over the last 5 years.

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€9,941,267
9,626 open across Europe right now
Buyer track record on Aperlena
765 notices tracked · 158 awarded
€170,986,269 in awarded contracts

Never miss a tender like this

19 new notices in Medical equipment & pharmaceuticals in Norway in the last 7 days. Get an email when new ones appear. Free.

Set up my alert
Source

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Jump to the search box
?
Show these shortcuts
Esc
Close